GlassScriptPhysician profile
Toral D Patel
NPI 1346409919
$5,935.26
in general payments reported to CMS, 2019-2025
9 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,050 · 2020: $21.08 · 2021: $66.32 · 2022: $1,210 · 2023: $176 · 2024: $80.98 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463 · Education: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.56 |
| Education | $125.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $4,056.25 | 2019-2021 | |
| Melinta Therapeutics, LLC | $1,266.94 | 2021-2024 | Vabomere |
| Galderma Laboratories, L.P. | $188.45 | 2019-2025 | |
| Gilead Sciences, INC. | $150.37 | 2021-2025 | |
| Janssen Biotech, INC. | $94.99 | 2023 | Tremfya |
| Shionogi INC | $78.22 | 2023-2024 | Fetroja |
| Incyte Corporation | $45.20 | 2023-2025 | Monjuvi, Zynyz, Jakafi |
| Pfizer INC. | $30.54 | 2023 | |
| Lilly USA, LLC | $24.30 | 2025 | Ebglyss, Taltz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toral Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.